ON THE PRESENCE IN ANTIPNEUMOCOCCUS SERUM OF TYPE-SPECIFIC PROTECTIVE ANTIBODY NOT NEUTRALIZED BY HOMOLOGOUS SPECIFIC SOLUBLE SUBSTANCE by Sabin, Albert B.
ON THE PRESENCE IN  ANTIPNEUMOCOCCUS SERUM OF 
TYPE-SPECIFIC  PROTECTIVE ANTIBODY NOT NEU- 
TRALIZED BY HOMOLOGOUS  SPECIFIC 
SOLUBLE SUBSTANCE* 
B~ ALBERT B. SABIN 
(From tke Department of Bacteriology and Immunology, New York University and 
Bdlerue Hospital Medical College, New York) 
(Received for publication, September 16, 1930) 
It has been generally assumed that the soluble specific carbohydrate 
of pneumococcus can neutralize the type-specific  protective action of 
antipneumococcus serum.  The purpose of the present communica- 
tion is to present experiments which indicate that antipneumococcus 
serum also contains type-specific protective antibody not neutralized 
by the homologous soluble specific carbohydrate. 
EX~EI~rME.NTAL 
The antipneumococcus horse serum used in these experiments was supplied by 
courtesy of Dr. Win. H. Park.  The soluble specific substance used was prepared 
by Dr. H. Sobotka, and on analysis has proved practically identical with that of 
Heidelberger, Goebel and Avery (1).  The mouse protection tests were performed 
at the Research Laboratories of the New York City Department of Health under 
the direction of MAss Georgia Cooper, to whom the author is greatly indebted. 
The protective unit of antipneumococcus serum, to which reference is made later 
on, may be defined as the smallest amount of antiserum, which will protect mice, 
inoculated intraperitoneally with 100,000 fatal doses of a  fully virulent culture, 
for 96 hours. 
Method  of  Total Precipitation  of  Anticarbokydrate Precipitins 
In  all  the experiments it was necessary to  know the amount of 
soluble specific substance  (SSS) required for complete precipitation 
of the antiserum, i.e.,  for the removal of all detectible anticarbohy- 
drate precipitins.  A  standard  simple method for  determining this 
* This study was aided by a  grant  from the  Littaner Fund  ~r Pneumonia 
Research in New York University. 
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quantity  of SSS had  to be elaborated.  Since  the point of maximum 
precipitation is difficult to judge and may not necessarily be the point 
of  complete  precipitation,  the  method  devised  consisted  essentially 
of a  rough titration  of the antiserum  with  the SSS.  In principle  the 
method was similar  to the one used by Pick  (2)  in the salt  fractiona- 
tion of proteins. 
To constant amounts of serum,  varying amounts of SSS  (the quantifies  in- 
creasing by 0.02 to 0.03 mg. for each cubic centimeter of serum) are added.  The 
mixtures are incubated in the water bath at 37°C. for 1 to 2 hours and then are 
put in the ice-box for 2 hours or overnight.  They are then centrifuged, and 0.02 
rag. or 0.03 rag. SSS per cubic centimeter of serum is added to each supernatant; 
the stay in water bath and ice-box incubation is repeated.  The supernatants of 
the mixtures in which complete precipitation occurred, show no further precipita- 
tion; the mixture containing the least amount of SSS, which fails to show further 
precipitation is considered to contain the required quantity of SSS.  The following 
protocol illustrates one such titration: 
2 co. serum + 0.6 co. 1-5000 (SSS)-~Ppt.  -  Supemat. + 0.2 cc. 1-5000 (SSS)-*Ppt. 
"  "  +0.8cc.  "  "  --~Ppt. -  "  q-  "  "  "  -~ " 
"  "  +  1.Occ.  "  "  --~Ppt.-  "  +  "  "  "  -~  " 
"  "  +  1.2 cc.  "  "  --*Ppt.  -  "  +  "  "  "  --*No  ppt. 
"  "  +  1.4cc.  "  "  --*Ppt.-  "  +  "  '"  "  --*"  " 
From this titration it may be seen that 1.0 cc. of a  1-5000 solution of SSS (in 
saline) per 2 cc. of serum was insu~cient,  whereas 1.2 cc. sui~ced for complete 
precipitation.  For more exact determination of the required amount of SSS, tests 
may be performed with quantities ranging between 1.0 to 1.2 cc. of 1-5000 SSS/2 
cc. serum; this yields a value of 0.1 to 0.12 rag. SSS per cubic centimeter of serum. 
When the supernatants are  incubated  with  additional  SSS, a slight precipitate 
frequently settles out after prolonged ice-box incubation (48 hours), which was not 
perceptible alter 2 hours' ice-box incubation.  Whether this additional precipitate 
is specific or not may be determined by the fact that specific precipitate  (after 
pouring off the supernatant) is soluble in dilute acid whereas sedimented denatured 
serum protein is insoluble in dilute acid.  For the experiments here recorded, the 
readings were made after 2 hours' ice-box incubation, since it was found that the 
supernatant failing to show any precipitation at that time always had some excess 
of SSS. 
A phenomenon similar to the "Danysz effect" in the combination of toxin with 
antitoxin was observed in relation to the combination  of SSS with homologous 
precipitin;  more  SSS  was  required  for  complete  precipitation  when  the  total 
quantity was added at once than when it was added in fractions of the total on 
successive days.  For example, 0.16 rag. SSS/cc. serum was required for complete 
precipitation when added at one time, whereas only 0.13 mg. SSS was sufficient ALBERT B.  SABIN  95 
when 0.05 rag. was added the first time and 0.02 nag. daily to the supernatant  on 
subsequent days. 
It is realized that the method just described does not give absolute 
values for the amount of SSS required for complete precipitation,  but 
the  approximate  values were considered sufficiently accurate for the 
subsequent experiments.  In  a  quantitative  study between the solu- 
ble specific substance of Type III pneumococcus and its homologous 
precipitin,  Heidelberger  and  Kendall  (3)  showed that  the  entire  re- 
action occurs in accordance with  the mass law.  The  data  obtained 
by my method of titration  are in the zone where only SSS is detect- 
ible in the supematant. 
In Viva Neutralization of Preclpitin and Protective Antibody by SSS 
Felton and Bailey (4) have assumed that SSS neutralizes the "pro- 
tective bodies" of antipneurnococcus serum in vivo, although they did 
not  demonstrate  complete inhibition  of the protective action. 
To determine  the in vivo neutralization  of protective antibody by 
SSS it was deemed advisable to combine the  SSS  and  antiserum  in 
one animal (rabbit), and then test the sertnn of that animal for protec- 
tion in the mouse, instead of injecting the antiserum,  SSS, and organ- 
isms in the same mouse at one time.  Since it has been demonstrated 
that small amounts of SSS are capable of annulling  the inhibitory ac- 
tion of the sera of naturally resistant animals on the growth of pneu- 
mococci in serum-leucocyte mixtures (5), and also that SSS can lower 
the  resistance  of mice  to  partially  attenuated  pneumococci  (4a),  it 
was intended,  by this  modification,  to  eliminate  any possible effect 
that  SSS may exert on factors involved in protection other than  the 
specific antibody in  the  serum.  The  following is  a  summary  of an 
experiment. 
Two rabbits of nearly equal weight were injected each with 5 cc. of Serum 121 
(Type I)  intravenously;  this  serum  had  about  1000 protective  units/cc,  and 
required 0.16 rag. SSS/cc. for complete precipitation or 0.8 nag. SSS for 5 cc. serum. 
Rabbit A (1700 gin.) received an intravenous  injection of 1.0 nag. Type I  SSS 
(0.2 nag. excess), 5 minutes  after the administration  of the serum.  Rabbit B 
(1820 gin.) received nothing outside of the 5 cc. of serum.  Rabbit A voided 15 cc. 
of urine 10 minutes after the injection of SSS.  This urine gave a positive test 
for SSS in a dilution of 1-4; the subsequent sample of urine voided  within  the 96  ANTIBODY  IN  ANTIPNEUMOCOCCUS  SERU'~ 
next 24 hours had no appreciable SSS.  4½ hours  after injection both rabbits 
were bled, and the serum was tested for SSS, precipitin, and protective antibody. 
The results shown in Table I indicate that although the precipitins 
were neutralized beyond the limits of detection, the protective anti- 
body was only partially neutralized, leaving approximately 50  to 60 
per cent.  The quantity of SSS that was lost in the urine was small 
compared with the amount injected,  and since the precipitins were 
completely neutralized it may be assumed that most of it combined 
with the antibody.  It is  realized that  the mouse protection test is 
TABLE  I 
In Vi~o Neutralization of Precipitin and Protective Antibody by SSS 
Rabbit 
'A 
B 
C 
D 
Substances injected 
5 ec. serum(I) 
1.Omg. SSS I 
5 cc. serum(I) 
Control 
5 cc. serum I 
1.0 rag. SSS 
5 cc. serum I 
Control 
Serum drawn  4t hours post iniection 
SSS  Precipitin 
Negative  Negative 
Negative  Positive 
1-10 
Negative  Negative 
Negative  Positive 
1-10 
Protective  antibody 
3 units/cc. 
5 units/ce. 
2 units/ce. 
4 units/cc. 
not sufficiently accurate to permit of mathematical deductions as to 
the quantity neutralized; yet the figures are definite enough to show 
that there is considerable protective antibody, presumably free from 
demonstrable anticarbohydrate precipitins,  which apparently is  not 
neutralized in vivo by SSS. 
Relationship  between  the Quantity  of SSS  Added  and  the Amounts  of 
Precipitins  and  Protective  Action  Neutralized 
The object of this experiment was to obtain additional information 
with regard to the relationship between the anticarbohydrate precipi- 
tins and the protective power of antipneumococcus serum from the ALSERr B.  SABra  97 
manner  in  which  different quantities  of  SSS  would  neutralize  their 
respective activity in the serum. 
The serum used in this experiment was 121 (Type I); it contained 1000 protec- 
tive units per cubic centimeter and required 0.16 nag. SSS/cc. for complete pre- 
cipitation.  To three 10 cc. samples of the serum, 1.6 rag., 0.8 mg., and 0.4 mg., 
SSS respectively were added, i.e.,  one portion received the full amount of SSS 
required for complete precipitation, another had one-half and the third portion 
one-fourth that amount.  The tubes were incubated in the water at 37°C. for 2 
hours, and in the ice-box overnight.  The precipitates obtained with 1.6 mg. SSS 
and 0.8 nag. appeared equally voluminous, whereas the volume of the precipitate 
with 0.4 rag. was somewhat smaller.  After centrifugation, the supernatants were 
tested for protective antibody and remaining precipitin.  This experiment was 
repeated with another Type I serum (607). 
TABLE II 
Removal of A nticarbokydrate  Precipitin and Protective A ntibody by Varying Amounts 
o/ SSs 
Protective units/cc.  Amount  of serum  Amount  of SSS I  Protective  unlts/ec.  Amount  of SSS for  complete  preciplta-  serum  added  of supernatant  tion of supernatant 
121, I 
1000 units 
607, I 
1000 units 
CC. 
10 
lO 
10 
10 
10 
10 
mg. 
1.6 
0.8 
0.4 
1.5 
0.75 
0.32 
100 
300 
100 
200 
500, <1000 
200, <500 
mg. 
0 
0.6-0.8 
1.0-1.2 
0 
0.6--0.7 
1.0-1.2 
The data presented in Table II indicate (1) a  lack  of proportional- 
ity between the quantity of SSS used for precipitation and the amount 
of protective action left in the supernatant, and (2) that complete neu- 
tralization  of the  anticarbohydrate  precipitins  does not  annul  all of 
the protective activity of the serum.  Quantitatively the data shown 
in  Table  II  appear  paradoxical.  Although  the  apparent  lack  of 
proportionality between  the  quantity of SSS  added  and  the amount 
of protective  antibody  neutralized  might  be  accounted  for by the 
possible non-specific adsorption of protective substance  on  the  SSS- 
precipitin complex, it seems unwise to express a  definite opinion. 98  ANTIBODY  IN ANTIPNEU]~OCOCCUS  SER~ 
Non-Specific Adsorption of Protective Antibody  by Specific 
Precipitate 
It has been demonstrated that when a serum, containing precipitin, 
is precipitated with homologous precipitinogen certain other antibodies 
contained in it may be carried down in the precipitate.  Antipneumo- 
coccus horse serum  contains both  so-called anti-"protein"  and  anti- 
carbohydrate  precipitins;  removal  of  either  one  by its  homologous 
precipitinogen has not resulted in an appreciable decrease of the other. 
The  results of the preceding  experiment,  however,  suggest that pro- 
tective  substance may be adsorbed  non-specifically by specific pre- 
cipitate; to determine this possibility the following test was performed. 
To 5 cc. of Type II antipneumococcus serum (101), 5 cc. of Type I serum (121) 
were added.  The Type II serum (101) required 0.12 rag. SSS/cc. for complete 
precipitation,  so that 0.6 cc. of a 1-1000 solution of SSS (II)  was added to the 
mixture.  After the usual water bath and ice-box incubation the precipitate was 
centrifuged and  the supernatant  tested for Type I  precipitins  and protective 
antibody.  It was found  that whereas the  Type I  precipitins were not appre- 
ciably affected (the amount of SSS I  required for complete precipitation of the 
supernatant was the same as that for the original serum), the protective action was 
d{minished from 1000 units/cc, of Type I serum to 400--600 units/cc.  Following 
the precipitation of a polyvalent (Types I and II)  antipneumococcus serum with 
Type I SSS, its protective action against Type II pneumococcus  was reduced from 
1000 units/cc,  to 600 units/cc.,  whereas the Type II anticarbohydrate  precipitins 
were not diminished as judged from the amount of Type II SSS required for com- 
plete precipitation. 
Protection by Specific Precipitates 
In  1915,  Gay and  Chickering  (6)  observed  that  the  precipitates, 
obtained by the interaction of water-solqble extracts of pneumococcus 
with  homologous  immune  serum,  protected  mice  against  infection 
almost as well as the original serum.  They interpreted this phenome- 
non as meaning that the precipitate was dissociated, and the liberated 
antibody was free to act.  Felton and Bailey (3)  concluded that  the 
specific precipitates  obtained with Type II  SSS  have  no  protective 
capacity.  It  is  possible,  however,  from  a  study of  their  protocols 
to reach an  opposite conclusion,  in which  case additional evidence is 
given for  the  view that  the precipitate  formed by SSS and immune ALBERT B.  SABIN  99 
serum can still protect against infection with the homologous type of 
pneumococcus. 
The data, bearing on this point, in Table III of Paper I (Felton and Bailey) are 
as~ follows: 
Precipitate with 2.5  rag.  SSS ..... protected almost as well  as control serum. 
"  "  0.25  "  SSS .... had no protection. 
"  "  0.025  "  SSS ..... protected as well as the control serum. 
Assuming that 0.25 nag. SSS is the optimum amount for complete precipitation, 
the precipitate produced with 2.5  nag, SSS,  probably smaller on  account of  a 
slight zone phenomenon does not carry down with it all of the SSS; the  specific 
precipitate has primarily only the combined antigen, leaving the rest in the super- 
natant, therefore, the precipitate with 2.5 rag. is essentially the same as the one 
with 0.25 nag. SSS and should not protect.  Similarly, the precipitate with 0.025 
rag. SSS although smaller in amount than that obtained 0.25 rag., still has both 
the antigen and the antibody (the excess  of antibody remaining in the super- 
natant); yet it protects as well as the control serum. 
Even ff the assumption made by Huntoon  (7), that an  insufficient 
amount of antigen combines with antibody in two ways  (1)  a  strong 
union, i.e., specific neutralization,  (2)  a  weak union corresponding to 
the adsorption of heterologous antibody by a precipitate, be applica- 
ble  in  this  case,  the  results of the above experiment are still unex- 
plained.  Since in certain of the experiments, suspensions of specific 
precipitate  had  some protective  action  Felton  and  Bailey  have  as- 
sumed that the specific precipitate acts "only to a  slight degree as a 
protective agent," and offer the same explanation as Gay and Chicker- 
ing, namely, that it is "due in part to dissociation before the substance 
is injected into the mouse, and also to dissociation within the animal." 
This explanation does not conform to the contention (Felton and Bai- 
ley in Paper I)  that SSS neutralizes the protective substance in ~/vo. 
For even if extensive in viIro dissociation of antigen-antibody complex 
were possible, as long as the two reagents are not separated, their in- 
jection into the body should cause their re-union, if in vivo neutrali- 
zation occurs; for extensive dissociation cannot be assumed to occur 
in  the  same  medium where  almost  complete neutralization  should 
occur. 
If, as was indicated in the foregoing experiments, the combination 
of  SSS  with homologous precipitin can  carry  down  protective  sub- 100  ANTIBODY  IN  ANTIPNEUMOCOCCUS  SERU~ 
stance by non-specific adsorption,  the results of Gay and Chickering 
and those of Felton and Bailey on the protective capacity of specific 
precipitates may be accounted for partially on that basis,  instead of 
entirely on the dissociation of specifically combined substances.  In 
our  own  experiments the protection  tests  with  specific precipitates 
were usually not so good as obtained by Gay and  Chickering  or  as 
shown in some of the data of Felton and Bailey.  A  specific precipi- 
tate obtained with the full amount of SSS required for complete pre- 
cipitation  of  the  anticarbohydrate  precipitins,  always  showed  con- 
siderable protective action but never as much as that removed by the 
precipitate from the serum.  The protection test performed at first 
with  a  suspension  of  the  specific precipitate  in  a  1  per  cent NaC1 
solution was later discontinued since accurate dilutions of a suspension 
of particles of varying size was impossible and the results were mark- 
edly irregular.  The  specific precipitate, however, is soluble in dilute 
acid, and more regular protection tests were obtained when the dilu- 
tions were made from a  solution of the precipitate in N/IO00  HC1; 
solutions stronger than N/IO0  HC1  have a  deleterious effect on  the 
antibody, particularly when a  day or more intervenes before the test 
is performed. 
The following protocol shows the data of a characteristic experiment with Type 
I  serum: 
(a)  Original serum ...............................  1000 protective units/cc. 
(b)  Supematant  from specific precipitate  with full amount  of SSS for 
complete ppt  .........................................  100 units/cc. 
(c)  Specific precipitate from 10 ec. serum dissolved in 10  cc. N/1000 HC1 
....................................................  200 units/cc. 
(d)  Specific precipitate from 10 cc. serum (with ~ amount of SSS required 
for complete precipitate) dissolved in 10 cc. N/1000 HC1..  200  units/cc. 
The sum of the protective action of the supernatant with that of 
the specific precipitate represents only about 30 per cent of the total; 
in other experiments this sum has been found to vary between 20 to 
50 per cent of the total.  Whether or not the remaining protective 
action corresponds to  that removed as a  result of the neutralization 
of the anticarbohydrate precipitins has not been determined as yet. 
Felton and Bailey (4b) showed that solutions of the specific precipi- ALBERT B.  SABn~  101 
tate in certain acid and alkaline zones exhibit marked protective action; 
their experiment was as follows. 
Some specific  precipitate was dissolved in N/20 HCI and a number of samples 
were adjusted to different pH, ranging between 4.4 and 9.8.  After this adjust- 
ment, any insoluble material was centrifuged out, and the supernatants were used 
in  tests  for  protective  antibody,  precipitinogen, and  agglutinin  (precipitin). 
Abundant  protection was  obtained  with  the  supernatants  from the samples 
adjusted in the range of pH 4.4-5.3 and pH 8.4-9.8.  Our own experiments indi- 
cate that the specific  precipitates are practically wholly soluble in these pH ranges 
and almost insoluble at neutrality. 
Felton and Bailey believed that their solutions contained two dis- 
sociated components (1)  protective antibody,  (2)  SSS.  Even if this 
assumption were true, the results of their protection tests are difficult 
to explain on this basis,  since not having separated the two compon- 
ents, the injection of these solutions into the body ought to result in 
their reunion.  But the precipitinogen and agglutinin tests with these 
supernatants,  upon which the contention of the  dissociated state of 
the precipitate is based, are not valid as is indicated by our experi- 
ments, which showed that precipitation obtained by the addition of 
homologous  serum  (test  for precipitinogen)  to  solutions  of  specific 
precipitate in the pH range 4.4-5.3 and 8.4-9.8 was non-specific, since 
normal serum and buffer solutions of a pH about 7.0 gave the same 
results.  The precipitation  is  apparently due  to  the shifting of  the 
pH to the zone of insolubility of the SSS-precipitin  complex by the 
serum or buffer solution.  The addition of homologous SSS  to  these 
solutions  also  precipitates  them  non-specifically,  heterologous  SSS 
producing  the  same  effect.  It  thus  appears  that  the  evidence  is 
against supposing that the solutions represented dissociated antigen- 
antibody complex, so that their protective action must be accounted 
for on another basis. 
To obtain further information on the possibility of such dissociation 
and to  determine the extent of in vivo dissociation of SSS-antibody 
complex, advantage was taken of the fact that  the rabbit kidney is 
virtually a  selective filter with  regard  to  SSS  and  antibody.  It is 
well known that the urine of a pneumococcus-infected rabbit contains 
SSS; our own experiments indicated that within a short time after the 
intravenous injection of purified SSS into a  rabbit,  the greatest por- 102  ANTIBODY  IN  ANTIPNEUMOCOCCUS  SERUM 
tion of it is  excreted in  the urine immediately, and  a  small  amount 
of SSS  remains  in  the  blood,  where it  can  be  detected for approxi- 
mately 10 days.  It is also known that antibody is not detectible in 
rabbit's  urine.  If the acid solution of specific precipitate contained 
dissociated  SSS-antibody  complex,  which  failed  to  reunite when  in- 
jected in vivo,  SSS should be found in the urine and precipitin in the 
blood. 
Protocols.--Specific  precipitate from 20  cc.  of antipneumococcus serum  607 
(Type I) with 3 rag. of SSS I (amount for complete precipitation) required 12 cc. 
of N/40 HC1 to dissolve completely; this was slowly injected into the  marginal 
ear vein of a rabbit (2260 gin.).  4 hours after injection blood was drawn from the 
marginal vein.  This rabbit serum had no demonstrable SSS or precipitin; it was 
tested for protective antibody in the range of 0.5 to 5 units per cc. and was found to 
contain 2 protective units/cc.  The total amount of urine voided within the next 
16 hours was 10 cc.; it had no demonstrable SSS.  In other similar experiments 
with Type I specific precipitates faint traces of SSS were occasionally detectible in 
the urine for a period of 24 to 48 hours after injection, but never any SSS or pre- 
cipitin in the serum although it always had protective action. 
When the original  urine failed to give a test for SSS it was concentrated as 
follows:  10 cc. or more of urine was dialyzed for 24 hours in running water.  The 
contents of the bag were then heated with a few drops of dilute acetic acid until it 
evaporated to 5 cc.; after filtration, 10 volumes of 95 per cent Cg-IsOH were added 
and the precipitate collected by centrifugation.  The precipitate was dissolved in 
1 cc. of 1 per cent NaCI solution and neutralized when necessary with N/50 NaOH. 
These  experiments  show  that  when  an  acid  solution  of  specific 
precipitate is injected intravenously into a  rabbit,  there is no indica- 
tion that the SSS-antibody complex exists in a  dissociated state.  In 
two  experiments,  the  urine  had  no  appreciable  SSS  and  the  rabbit 
serum,  containing no demonstrable SSS or precipitin,  had 2  units of 
protective antibody per cubic centimeter.  In the experiments where 
SSS did appear in the urine it was so slight in amount compared with 
the  quantity  injected,  combined  in  the  specific precipitate,  that  it 
may represent uncombined excess which was either introduced as such 
or  resulted  from  slight  dissociation.  That  appreciable  dissociation 
did not occur is evident from the fact that at no time was anticarbo- 
hydrate precipitin demonstrable in the rabbit serum.  These experi- 
ments,  therefore,  bring  additional  evidence  to  the  view  that  the 
protective action of the  specific precipitates is probably due  to  the 
liberation of non-specifically adsorbed protective antibody. ALBERT  B.  SABI"N  103 
Protective Action  of Antipneumococcus  Serum  after  Complete Precipi- 
tation of the Anticarbohydrate  Precipitins 
At the 'very beginning of this investigation it was observed that after 
complete precipitation of the anticarbohydrate precipitins from Type 
I  antipneumococcus sera,  the supernatant always had some residual 
protective action,  the amount varying from 10 to 30 per cent of the 
original serum.  The residual protective antibody in the supematants 
of Type II  sera  were  considerably  less,  but  nevertheless definite. 
TABLE  III 
Protective Action of Antitmeuraococcus Serum after Complete Precipitation of the 
Anticarbohydrate Precipitins 
Serum 
121 
170 
607 
Concentrated 
Felton 
101 
40 
I 
I 
I 
I 
II 
II' 
anount SS~  c 
equired for 
complete 
ppt.]cc. 
rag. 
0.16 
0.04 
0.15 
0.24 
0.12 
0.08 
Protective 
units in 
original 
set'Bin 
1000 
100 
1000 
2000 
3O0 
500 
Protective 
units  in 
supernatant 
lO0-300g 
20 
200 
5OO 
10 
20, <S0 
200,  <500* 
Protective 
units in 
supernatant 
+  50 per cent 
excess SSS 
100-300~g 
20 
200 
500 
I0 
Not done 
Protective 
units in 
supematant 
+  100 per cent 
excess SSS 
100-300 
20 
200 
500 
10 
Not done 
Different supernatants tested on various occasions gave values ranging be- 
tween 100 to 300 protective units/cc. 
* This figure represents the protection afforded by the suspension of the specific 
precipitate in the supernatant. 
When these supernatants were tested against a heterologous type of 
pneumococcus, they showed no appreciable protective action.  It was 
thus evident that the protective antibody remaining in the superna- 
tants, which were practically free of antJcarbohydrate precipitins, was 
type-specific.  To determine the relation of this type-specific protec- 
tive antibody to  SSS,  the supernatants were mixed with additional 
SSS  in  amounts  equivalent  to 50 per cent and  I00 per cent of the 
quantity  originally  required  for  complete  precipitation.  As  may 
be  seen  from  Table lit,  the residual protective antibody in the su- 104  ANTIBODY  IN ANTIPNE~OCOCCUS  SERUM" 
pernatants was never neutralized by SSS.  From  these results, taken 
together with the observations of the foregoing experiments,  it may 
be  concluded  that  there is in  antipneumococcus  serum  type-specific 
protective antibody which is not neutralized by SSS and apparently 
distinct from the anticarbohydrate precipitins.  The amount of this 
protective antibody in an antiserum is difficult to estimate, but it is 
undoubtedly more than the residue found in the supernatant since a 
considerable  quantity  is  probably  adsorbed  apparently  non-specifi- 
cally on the SSS-precipitin precipitate. 
Is There Another Type-Specific Antigen in the Pneumococcus in 
Addition to the SSS? 
The contention that there is a type-specific protective antibody, not 
neutralized by SSS,  necessarily presupposes  the existence of another 
antigen.  Since each antibody must have its corresponding  antigen, 
complete proof for the existence of a  type-specific antibody distinct 
from  the  anticarbohydrate  precipitin  will  not  be  available  until  a 
type-specific neutralizing antigen is found which is distinct from SSS. 
The  following experiment offers an  indication  that such  an  antigen 
may actually exist.* 
ProDcols.--The  serum  used  was  Type  I  (607) containing  1000 protective 
units/cc.; the quantity of SSS required for complete precipitation was 0.15 mg./cc. 
20 cc. of Serum 607 was precipitated with 3 mg. of SSS I.  After the routine 
water bath and ice-box incubation,  the supernatant obtained by centrifugation, 
was divided into several portions, which were treated as follows: 
(a)  Supernatant +  0.075 mg. SSS/cc.  (50 per cent excess of SSS). 
(b)  "  +  0.15  rag. SSS/cc. (100 per cent  ......  ). 
(c)  "  4.6 cc. +  2 cc.  emulsion of Type I pneumococci (heatkilled) + 
1.4 cc. saline. 
(d) Supematant 4.6 cc. +  2 cc.  emulsion  of Type II pneumococci (heatkilled) + 
1.4 cc. saline. 
The organisms used for absorption  were obtained each from 200 cc. of an 18 
hour broth culture (heated at 56  ° for 30 minutes) by centrifugation.  The sedi- 
mented organisms from 200 cc. were emulsified in 4 cc. of saline. 
* Since the writing of this communication, Enders, J. F., Y. Exp. Med., 1930, 
52, 235, presented evidence "for the existence of a type-specific substance distinct 
from the specific carbohydrate in the autolytic products of Pneumococcus Type 
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The portions of supernatant  mixed with SSS and those with the organisms were 
thoroughly shaken and incubated in the water bath at 37°Cr for 2 hours and then 
in the ice-box overnight.  It is interesting to observe especially in view of the fact 
that the supernatant  had no appreciable protection  for Type II pneumococcus, 
that it agglutinated both the Type I and the Type II pneumococci; the agglutina- 
tion titer for Type I was 1-16 and for Type  ~"  II pneumococcus, 1-8.  After incuba- 
tion,  the organisms were centrifuged and  all the supernatants  were tested for 
protection.  The results of the test were as follows: 
Original serum  ............................  1000 protective units/cc. 
Supematant ..............................  200  "  " 
Supematant  50 per cent excess SSS  .....  ....  200  "  " 
"  i00 per  cent  "  "  .........  200  "  " 
Supernatant  treated  with  Type  I  pneumo- 
cocci ..................................  less than 50 protective units/cc. 
Supematant  treated  with  Type  II  pneumo- 
cocci  ...................................  200  "  " 
It will be seen that the residual protective antibody in  the superna- 
tant is not neutralized by SSS nor by absorption with Type II pneu- 
mococci,  but  is  definitely  absorbed  with  the  homologous  Type  I 
pneumococci.  The agglutination  of the organisms which occurred in 
the supernatant probably did not cause non-specific adsorption,  since 
with  the  heterologous  pneumococci  there  was no  diminution  in  the 
protective  antibody  present.  It  may be  assumed,  therefore,  that 
this  neutralization  was  specific,  and  unless  SSS  in  the  organism  is 
capable  of  neutralizing  antibody  which  SSS  in  solution cannot,  it 
must be conceded that some other substance in the pneumococcus was 
the responsible agent. 
DISCUSSION 
The mechanism  whereby antipneumococcus serum averts  death  of 
a pneumococcus-infected animal is not understood.  The study of the 
substances which may neutralize this protective activity should yield 
valuable information on the problem of its mode of action.  The car- 
bohydrate fraction of the pneumococcus has been assumed capable  of 
neutralizing  the protective action of antipneumococcus serum on  the 
basis of the following observations: 
1.  "Soluble  neutralizing  substances"  for  the  homologous  immune 
bodies (8, 9) were demonstrated in pneumococcus infected serums and 
exudates which are known to contain SSS (10). 106  ANTIBODY  IN  ANTIPNEUMOCOCCUS  SERUM 
2.  Neutralization of  the protective action by SSS  in  vivo  and  in 
vitro  (4). 
3.  Absorption  of  the  protective  antibody  and  the  type-specific 
agglutinins with S-producing pneumocoeci (Type II) as well as with 
the filtrates of their broth cultures (11). 
In the foregoing experiments it was shown that in vivo,  the SSS of 
Type I  pneumococcus only partially neutralizes the protective  anti- 
body, and that specific precipitates resulting from the ir~ vitro union 
of SSS with anticarbohydrate precipifin exert a  type-specific protec- 
tive action.  Heidelberger and Kendall (3) observed that the  SSS of 
Type III pneumococcus can combine with its homologous antibody 
in  varying proportions.  Should  the  same  principles  apply  to  the 
combination of the SSS of other types of pneumocoeci with their anti- 
bodies, it would be theoretically possible for certain specific precipi- 
tates to react with SSS in the organisms, and thus exert protection; 
similarly the  specific  precipitates,  having the maximum amount  of 
SSS in combination should not be protective.  However, in the fore- 
going  experiments  the  precipitates  obtained  with  the  maximum 
amount of SSS still showed definite protection; since it was observed 
that these precipitates can adsorb non-specifically  heterologous  pro- 
tective antibody, it appeared possible  that their homologous protec- 
tive action might similarly be due to a liberation of non-specifically 
adsorbed antibody. 
After  the  total  precipitation  of  the  anficarbohydrate precipitins, 
Type  I  anfipneumococcus serum  retained a  definite amount of  its 
type-specific protective action,  which was not neutralized by  addi- 
tional SSS, although it was absorbed only with the homologous viru- 
lent pneumococci.  It appears possible,  therefore, that this  residual 
protection is exerted by an  antibody distinct from the  anticarbohy- 
drate precipifins.  The supernatants containing the residual protec- 
tion had a low agglutination titer for the homologous pneumococcus, 
but nevertheless somewhat higher than for heterologous pneumococci; 
whether or not this fact bears any relationship to the protective ac- 
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SU~r~r~.RY 
The mutual relationship of the anticarbohydrate precipitins and the 
protective  action  in  antipneumococcus sera  to  the  soluble  specific 
substance was  investigated.  The  assumption  is  made  that  there 
exists in antipneumococcus serum, type-specific  protective antibody 
which is distinct from the anticarbohydrate precipitins and is not neu- 
tralized by the soluble specific substance.  This assumption is based 
upon the following observations in experiments which were conducted 
primarily with Type I  antipneumococcus horse serum. 
1. Lack of proportionality between the quantity of SSS added and 
the amount of anticarbohydrate precipitin and protective action neu- 
tralized. 
2.  Protective capacity of specific precipitates  (SSS-precipitin  com- 
plex) is accounted for on the basis of a liberation of  non-specifically 
adsorbed protective antibody. 
3.  SSS only partially neutralizes the protective action of antipneu- 
mococcus serum in vivo. 
4.  Type-specific protective antibody remains in  antipneumococcus 
serum after complete precipitation of the anticarbohydrate precipifins. 
5. This residual type-specific protective antibody is not neutralized 
by additional SSS nor by absorption with heterologous pneumococci; 
it is definitely absorbed by the homologous pneumococci. 
I  wish to express my indebtedness to Prof. Win. H.  Park  for the 
most valuable guidance and criticism during the course of this work. 
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